Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 2/20 | 0.49 |
| ▸ | THRA | P10827 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.48 |
| ▸ | ESR1 | P03372 | 2/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | TACR2 | P21452 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | SHBG | P04278 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30986895 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL672745 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL639390 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL10901180 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL673710 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL3958992 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL672747 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL3965860 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL21611785 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 | |
| SCHEMBL30398957 | 0.97 | ENPP2 (0.53) | ENPP2THRBTHRAS1PR1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796800-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2017-10-24 | — | — | US | claimed |
| US-20160108153-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2016-04-21 | — | — | US | claimed |
| US-8188201-B2 | Bulk polymerization process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2012-05-29 | — | — | US | claimed |
| US-20100004413-A1 | BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2010-01-07 | — | — | US | claimed |
| EP-2075266-A2 | Bulk polymerization process for producing polydienes | Bridgestone Corporation (JP) | 2009-07-01 | — | — | EP | claimed |
| EP-3969490-B1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS | BRIDGESTONE CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12410263-B2 | Modified high-Cis polybutadiene polymer, related methods and rubber compositions | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-12371516-B2 | Aged lanthanide-based catalyst systems and their use in the preparation of cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| US-12264232-B2 | Modified high-cis polybutadiene polymer, related methods and tire components | BRIDGESTONE CORPORATION (JP) | 2025-04-01 | — | — | US | disclosed |
| US-20250066516-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | BRIDGESTONE CORPORATION (JP) | 2025-02-27 | — | — | US | disclosed |
| CN-113825777-B | Modified high cis polybutadiene polymers, related methods and tire components | 株式会社普利司通 | 2025-01-28 | — | — | CN | disclosed |
| US-7008899-B2 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2006-03-07 | — | — | US | disclosed |
| WO-2005061563-A1 | BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2005-07-07 | — | — | WO | disclosed |
| US-20050131174-A1 | Bulk polymerization process for producing polydienes | BRIDGESTONE CORP. | 2005-06-16 | — | — | US | disclosed |
| US-6897270-B2 | Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | BRIDGESTONE CORPORATION (JP) | 2005-05-24 | — | — | US | disclosed |
| US-20050038215-A1 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2005-02-17 | — | — | US | disclosed |
| US-20040116638-A1 | Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | BRIDGESTONE CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| US-6699813-B2 | COMPOSITION THAT IS COMBINATION OF OR REACTION PRODUCT OF LANTHANIDE COMPOUND, ALKYLATING AGENT, NICKEL-CONTAINING COMPOUND, AND OPTIONALLY HALOGEN-CONTAINING COMPOUND THAT INCLUDES ONE OR MORE LABILE HALOGEN ATOMS | BRIDGESTONE CORPORATION (JP) | 2004-03-02 | — | — | US | disclosed |
| US-20030176276-A1 | Lanthanide-based catalyst composition for the manufacture of polydienes | BRIDGESTONE CORPORATION (JP) | 2003-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | MALT1, INO80C, RTCB | ENPP2 4652/4885THRB 529/4885THRA 994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.